{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T20:03:23Z","timestamp":1788465803787,"version":"build-2803163510"},"reference-count":39,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2018,11,13]],"date-time":"2018-11-13T00:00:00Z","timestamp":1542067200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21CA187730"],"award-info":[{"award-number":["R21CA187730"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01DE023641"],"award-info":[{"award-number":["R01DE023641"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"UF Health Cancer Center"},{"name":"Gatorade Trust Fund"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>The LKB1 tumor suppressor gene is commonly inactivated in non-small cell lung carcinomas (NSCLC), a major form of lung cancer. Targeted therapies for LKB1-inactivated lung cancer are currently unavailable. Identification of critical signaling components downstream of LKB1 inactivation has the potential to uncover rational therapeutic targets. Here we investigated the role of INSL4, a member of the insulin\/IGF\/relaxin superfamily, in LKB1-inactivated NSCLCs.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>INSL4 expression was analyzed using global transcriptome profiling, quantitative reverse transcription PCR, western blotting, enzyme-linked immunosorbent assay, and RNA in situ hybridization in human NSCLC cell lines and tumor specimens. INSL4 gene expression and clinical data from The Cancer Genome Atlas lung adenocarcinomas (n\u2009=\u2009515) were analyzed using log-rank and Fisher exact tests. INSL4 functions were studied using short hairpin RNA (shRNA) knockdown, overexpression, transcriptome profiling, cell growth, and survival assays in vitro and in vivo. All statistical tests were two-sided.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>INSL4 was identified as a novel downstream target of LKB1 deficiency and its expression was induced through aberrant CRTC-CREB activation. INSL4 was highly induced in LKB1-deficient NSCLC cells (up to 543-fold) and 9 of 41 primary tumors, although undetectable in all normal tissues except the placenta. Lung adenocarcinomas from The Cancer Genome Atlas with high and low INSL4 expression (with the top 10th percentile as cutoff) showed statistically significant differences for advanced tumor stage (P\u2009&lt;\u2009.001), lymph node metastasis (P\u2009=\u2009.001), and tumor size (P\u2009=\u2009.01). The INSL4-high group showed worse survival than the INSL4-low group (P\u2009&lt;\u2009.001). Sustained INSL4 expression was required for the growth and viability of LKB1-inactivated NSCLC cells in vitro and in a mouse xenograft model (n\u2009=\u20095 mice per group). Expression profiling revealed INSL4 as a critical regulator of cell cycle, growth, and survival.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>LKB1 deficiency induces an autocrine INSL4 signaling that critically supports the growth and survival of lung cancer cells. Therefore, aberrant INSL4 signaling is a promising therapeutic target for LKB1-deficient lung cancers.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/jnci\/djy166","type":"journal-article","created":{"date-parts":[[2018,8,24]],"date-time":"2018-08-24T15:12:33Z","timestamp":1535123553000},"page":"664-674","source":"Crossref","is-referenced-by-count":27,"title":["Role of INSL4 Signaling in Sustaining the Growth and Viability of LKB1-Inactivated Lung Cancer"],"prefix":"10.1093","volume":"111","author":[{"given":"Rongqiang","family":"Yang","sequence":"first","affiliation":[{"name":"Department of Molecular Genetics and Microbiology"},{"name":"UF Health Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven W","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Molecular Genetics and Microbiology"},{"name":"UF Health Cancer Center"},{"name":"Department of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zirong","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Molecular Genetics and Microbiology"},{"name":"UF Health Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Molecular Genetics and Microbiology"},{"name":"UF Health Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Ni","sequence":"additional","affiliation":[{"name":"Department of Molecular Genetics and Microbiology"},{"name":"UF Genetics Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongtao A","family":"Fu","sequence":"additional","affiliation":[{"name":"Department of Pathology, Immunology and Laboratory Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianrong","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Molecular Genetics and Microbiology"},{"name":"UF Health Cancer Center"},{"name":"Department of Biochemistry and Molecular Biology, College of Medicine, University of Florida, Gainesville, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederic J","family":"Kaye","sequence":"additional","affiliation":[{"name":"UF Health Cancer Center"},{"name":"Department of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lizi","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Molecular Genetics and Microbiology"},{"name":"UF Health Cancer Center"},{"name":"UF Genetics Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,11,13]]},"reference":[{"key":"2019071119555324500_djy166-B1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-319-24223-1_1","article-title":"Lung cancer statistics","volume":"893","author":"Torre","year":"2016","journal-title":"Adv Exp Med Biol"},{"issue":"1","key":"2019071119555324500_djy166-B2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21387","article-title":"Cancer statistics","volume":"67","author":"Siegel","year":"2017","journal-title":"CA Cancer J Clin"},{"issue":"5676","key":"2019071119555324500_djy166-B3","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1126\/science.1099314","article-title":"EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy","volume":"304","author":"Paez","year":"2004","journal-title":"Science"},{"issue":"13","key":"2019071119555324500_djy166-B4","doi-asserted-by":"crossref","first-page":"4275","DOI":"10.1158\/1078-0432.CCR-08-0168","article-title":"EML4-ALK fusion gene and efficacy of an ALK kinase inhibitor in lung cancer","volume":"14","author":"Koivunen","year":"2008","journal-title":"Clin Cancer Res"},{"issue":"11","key":"2019071119555324500_djy166-B5","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1038\/nrc2947","article-title":"Rational, biologically based treatment of EGFR-mutant non-small-cell lung cancer","volume":"10","author":"Pao","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"2019071119555324500_djy166-B6","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1146\/annurev.biochem.75.103004.142702","article-title":"LKB1-dependent signaling pathways","volume":"75","author":"Alessi","year":"2006","journal-title":"Annu Rev Biochem"},{"issue":"8","key":"2019071119555324500_djy166-B7","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/nrc2676","article-title":"The LKB1-AMPK pathway: metabolism and growth control in tumour suppression","volume":"9","author":"Shackelford","year":"2009","journal-title":"Nat Rev Cancer"},{"issue":"24","key":"2019071119555324500_djy166-B8","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1056\/NEJM198706113162404","article-title":"Increased risk of cancer in the Peutz-Jeghers syndrome","volume":"316","author":"Giardiello","year":"1987","journal-title":"N Engl J Med"},{"issue":"6663","key":"2019071119555324500_djy166-B9","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/34432","article-title":"A serine\/threonine kinase gene defective in Peutz-Jeghers syndrome","volume":"391","author":"Hemminki","year":"1998","journal-title":"Nature"},{"issue":"40","key":"2019071119555324500_djy166-B10","doi-asserted-by":"crossref","first-page":"5911","DOI":"10.1038\/sj.onc.1210418","article-title":"Prevalence and specificity of LKB1 genetic alterations in lung cancers","volume":"26","author":"Matsumoto","year":"2007","journal-title":"Oncogene"},{"issue":"7216","key":"2019071119555324500_djy166-B11","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/nature07423","article-title":"Somatic mutations affect key pathways in lung adenocarcinoma","volume":"455","author":"Ding","year":"2008","journal-title":"Nature"},{"issue":"7511","key":"2019071119555324500_djy166-B12","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nature13385","article-title":"Comprehensive molecular profiling of lung adenocarcinoma","volume":"511","author":"Collisson","year":"2014","journal-title":"Nature"},{"issue":"4","key":"2019071119555324500_djy166-B13","doi-asserted-by":"crossref","first-page":"e5137.","DOI":"10.1371\/journal.pone.0005137","article-title":"Somatic LKB1 mutations promote cervical cancer progression","volume":"4","author":"Wingo","year":"2009","journal-title":"PLoS One"},{"issue":"19","key":"2019071119555324500_djy166-B14","doi-asserted-by":"crossref","first-page":"5102","DOI":"10.1093\/emboj\/cdg490","article-title":"MO25alpha\/beta interact with STRADalpha\/beta enhancing their ability to bind, activate and localize LKB1 in the cytoplasm","volume":"22","author":"Boudeau","year":"2003","journal-title":"EMBO J"},{"issue":"1","key":"2019071119555324500_djy166-B15","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/sj.onc.1203227","article-title":"Epigenetic inactivation of LKB1 in primary tumors associated with the Peutz-Jeghers syndrome","volume":"19","author":"Esteller","year":"2000","journal-title":"Oncogene"},{"issue":"6","key":"2019071119555324500_djy166-B16","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.cell.2012.08.029","article-title":"Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing","volume":"150","author":"Imielinski","year":"2012","journal-title":"Cell"},{"issue":"2","key":"2019071119555324500_djy166-B17","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.molcel.2008.12.026","article-title":"Oncogenic B-RAF negatively regulates the tumor suppressor LKB1 to promote melanoma cell proliferation","volume":"33","author":"Zheng","year":"2009","journal-title":"Mol Cell"},{"issue":"2","key":"2019071119555324500_djy166-B18","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ccr.2012.12.008","article-title":"LKB1 inactivation dictates therapeutic response of non-small cell lung cancer to the metabolism drug phenformin","volume":"23","author":"Shackelford","year":"2013","journal-title":"Cancer Cell"},{"issue":"6","key":"2019071119555324500_djy166-B19","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.ccr.2010.04.026","article-title":"Integrative genomic and proteomic analyses identify targets for Lkb1-deficient metastatic lung tumors","volume":"17","author":"Carretero","year":"2010","journal-title":"Cancer Cell"},{"issue":"7391","key":"2019071119555324500_djy166-B20","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/nature10937","article-title":"A murine lung cancer co-clinical trial identifies genetic modifiers of therapeutic response","volume":"483","author":"Chen","year":"2012","journal-title":"Nature"},{"issue":"8","key":"2019071119555324500_djy166-B21","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1158\/2159-8290.CD-13-0015","article-title":"Metabolic and functional genomic studies identify deoxythymidylate kinase as a target in LKB1-mutant lung cancer","volume":"3","author":"Liu","year":"2013","journal-title":"Cancer Discov"},{"issue":"1","key":"2019071119555324500_djy166-B22","doi-asserted-by":"crossref","first-page":"358.","DOI":"10.1093\/jnci\/dju358","article-title":"Role of LKB1-CRTC1 on glycosylated COX-2 and response to COX-2 inhibition in lung cancer","volume":"107","author":"Cao","year":"2015","journal-title":"J Natl Cancer Inst"},{"issue":"5 Pt 2","key":"2019071119555324500_djy166-B23","doi-asserted-by":"crossref","first-page":"70R","DOI":"10.1203\/01.PDR.0000159573.55187.CA","article-title":"New members of the insulin family: regulators of metabolism, growth and now \u2026 reproduction","volume":"57","author":"Lu","year":"2005","journal-title":"Pediatr Res"},{"issue":"3","key":"2019071119555324500_djy166-B24","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/nrc3215","article-title":"The insulin and insulin-like growth factor receptor family in neoplasia: an update","volume":"12","author":"Pollak","year":"2012","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"2019071119555324500_djy166-B25","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/(SICI)1098-2795(199810)51:2<123::AID-MRD1>3.0.CO;2-S","article-title":"Insulin-like 4 (INSL4) gene expression in human embryonic and trophoblastic tissues","volume":"51","author":"Laurent","year":"1998","journal-title":"Mol Reprod Dev"},{"issue":"4","key":"2019071119555324500_djy166-B26","first-page":"1020","article-title":"Early placenta insulin-like growth factor (pro-EPIL) is overexpressed and secreted by c-erbB-2-positive cells with high invasion potential","volume":"62","author":"Brandt","year":"2002","journal-title":"Cancer Res"},{"issue":"4","key":"2019071119555324500_djy166-B27","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1677\/erc.1.00975","article-title":"Expression of early placenta insulin-like growth factor in breast cancer cells provides an autocrine loop that predominantly enhances invasiveness and motility","volume":"12","author":"Brandt","year":"2005","journal-title":"Endocr Relat Cancer"},{"issue":"1","key":"2019071119555324500_djy166-B28","doi-asserted-by":"crossref","first-page":"803.","DOI":"10.1186\/s12885-015-1827-3","article-title":"Gene expression profiling analysis of CRTC1-MAML2 fusion oncogene-induced transcriptional program in human mucoepidermoid carcinoma cells","volume":"15","author":"Chen","year":"2015","journal-title":"BMC Cancer"},{"issue":"6","key":"2019071119555324500_djy166-B29","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1172\/JCI85250","article-title":"cAMP\/CREB-regulated LINC00473 marks LKB1-inactivated lung cancer and mediates tumor growth","volume":"126","author":"Chen","year":"2016","journal-title":"J Clin Invest"},{"issue":"7656","key":"2019071119555324500_djy166-B30","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nature22359","article-title":"CPS1 maintains pyrimidine pools and DNA synthesis in KRAS\/LKB1-mutant lung cancer cells","volume":"546","author":"Kim","year":"2017","journal-title":"Nature"},{"issue":"3","key":"2019071119555324500_djy166-B31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jnci\/djw231","article-title":"Role of CPS1 in cell growth, metabolism and prognosis in LKB1-inactivated lung adenocarcinoma","volume":"109","author":"Celiktas","year":"2017","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"2019071119555324500_djy166-B32","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1074\/mcp.M113.035600","article-title":"Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics","volume":"13","author":"Fagerberg","year":"2014","journal-title":"Mol Cell Proteomics"},{"key":"2019071119555324500_djy166-B33","doi-asserted-by":"crossref","first-page":"149","DOI":"10.4137\/CIN.S7226","article-title":"GENT: Gene expression database of normal and tumor tissues","volume":"10","author":"Shin","year":"2011","journal-title":"Cancer Inform"},{"issue":"12","key":"2019071119555324500_djy166-B34","doi-asserted-by":"crossref","first-page":"e82241.","DOI":"10.1371\/journal.pone.0082241","article-title":"Online survival analysis software to assess the prognostic value of biomarkers using transcriptomic data in non-small-cell lung cancer","volume":"8","author":"Gy\u0151rffy","year":"2013","journal-title":"PLoS One"},{"issue":"4","key":"2019071119555324500_djy166-B35","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/onc.2011.247","article-title":"Altered LKB1\/CREB-regulated transcription co-activator (CRTC) signaling axis promotes esophageal cancer cell migration and invasion","volume":"31","author":"Gu","year":"2012","journal-title":"Oncogene"},{"issue":"11","key":"2019071119555324500_djy166-B36","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1038\/onc.2009.453","article-title":"Enhanced activity of the CREB co-activator Crtc1 in LKB1 null lung cancer","volume":"29","author":"Komiya","year":"2010","journal-title":"Oncogene"},{"issue":"2","key":"2019071119555324500_djy166-B37","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1006\/geno.1995.9980","article-title":"Cloning of a new member of the insulin gene superfamily (INSL4) expressed in human placenta","volume":"29","author":"Chassin","year":"1995","journal-title":"Genomics"},{"issue":"4","key":"2019071119555324500_djy166-B38","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1095\/biolreprod.102.010322","article-title":"Placenta-specific INSL4 expression is mediated by a human endogenous retrovirus element","volume":"68","author":"Bieche","year":"2003","journal-title":"Biol Reprod"},{"issue":"7","key":"2019071119555324500_djy166-B39","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1210\/jc.2012-3566","article-title":"DNA methylation signatures identify biologically distinct thyroid cancer subtypes","volume":"98","author":"Rodr\u00edguez-Rodero","year":"2013","journal-title":"J Clin Endocrinol Metab"}],"container-title":["JNCI: Journal of the National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jnci\/article-pdf\/111\/7\/664\/28924593\/djy166.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,23]],"date-time":"2019-09-23T06:42:49Z","timestamp":1569220969000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jnci\/article\/111\/7\/664\/5181309"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,13]]},"references-count":39,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2018,11,13]]},"published-print":{"date-parts":[[2019,7,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jnci\/djy166","relation":{},"ISSN":["0027-8874","1460-2105"],"issn-type":[{"value":"0027-8874","type":"print"},{"value":"1460-2105","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,7]]},"published":{"date-parts":[[2018,11,13]]}}}